ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations. May 07, 2019 12:20 PM Eastern Daylight Time. ANAHEIM, ...

There have been a number of small-sized underpowered randomized controlled trials to assess effects of telmisartan on flow-mediated dilatation (FMD). To determine whether telmisartan increases FMD ...

In this multicenter, randomized, controlled trial, we assigned infants younger than 12 months of age who had bronchiolitis and a need for supplemental oxygen therapy to receive either high-flow ...

This was a pragmatic, single-blinded, parallel randomized control trial held from November 2015 to June 2017, including a 30-day post index surgery follow-up.

Of those screened (n = 531), 132 were deemed eligible and randomly assigned to the immediate treatment (n = 63) or waitlist control group (n = 69). Trial arms did not differ in the number of treatment ...

BACKGROUND: Conflicting recommendations exist on whether high-flow nasal cannula (HFNC) oxygen therapy should be administered to adult patients in critical care with acute hypoxemic respiratory ...

RIBBON-1, an international, multicenter, phase III, randomized, placebo-controlled trial, was designed to evaluate the efficacy and safety of BV in combination with chemotherapy regimens, including ...

Our study was an international, blinded, randomized, controlled trial that used a 2-by-3 factorial design to evaluate the effects of high versus low versus very low (gravity flow) irrigation ...